Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity.
In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity.
Curriculum: Metabolic Problems and Endocrinology
CPD Points: 0.25
Time to complete this course: 15 minutes
Date of publication: 6 February 2025
Mode: Podcast
Remove from search results: No
Podcast icon: Yes
Course index: Hide
Section titles: Hide